# DAY101 In Gliomas and Other Tumors

> **NCT03429803** · PHASE1 · COMPLETED · sponsor: **Karen D. Wright, MD** · enrollment: 44 (actual)

## Conditions studied

- Low-grade Glioma

## Interventions

- **DRUG:** DAY101

## Key facts

- **NCT ID:** NCT03429803
- **Lead sponsor:** Karen D. Wright, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03429803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03429803, "DAY101 In Gliomas and Other Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03429803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*